The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection

Clinical and Experimental Immunology

Volumn 152, Issue 2, 2008, Pages 239-244

  Chin, G K ^a   Adams, C L ^a   Carey, B S ^a   Shaw, S ^b   Tse, W Y ^a   Kaminski, E R ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Acute renal allograft rejection; IFN ; IL 12 genetic polymorphisms; Neopterin

Indexed keywords

CREATININE; GAMMA INTERFERON; INTERLEUKIN 12P40; NEOPTERIN;

3' UNTRANSLATED REGION; ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; HUMAN; KIDNEY GRAFT REJECTION; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; FEMALE; GRAFT REJECTION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12 SUBUNIT P40; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPTERIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 42049089163     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03632.x     Document Type: Article

References (35)

1. Matas AJ, Gillingham KJ, Payne WD, Najarain JS. The impact of an acute rejection episode on long-term renal allograft survival. Transplantation 1994 57 : 857 79.
2. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003 349 : 2326 33.
3. Cartwright N, Demaine A, Jahromi M, Sanders H, Kaminski ER. A study of cytokine protein secretion, frequencies of cytokine expressing cells and IFN-γ gene polymorphisms in normal individuals. Transplantation 1999 68 : 1546 52.
4. Kaminski ER, Kaminski A, Bending MR et al. In vitro cytokine profiles and their relevance to rejection following renal transplantation. Transplantation 1995 60 : 703 6.
5. Cartwright NH, Demaine AG, Hurlock NJ et al. Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching. Transpl Immunol 2000 8 : 109 14.
6. Suresh V, Carey BS, Shaw S et al. Retrospective study of the prognostic impact of cytokine secretion in mixed lymphocyte culture on long-term graft function following allogeneic renal transplantation. Transplant Int 2005 18 : 1067 71.
7. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnot PJ, Hutchinson IV. In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene. Eur J Immunogenet 1999 26 : 1 3.
8. Cartwright NH, Keen LJ, Demaine AG et al. A study of cytokine gene polymorphisms and protein secretion in renal transplantation. Transplant Immunol 2001 8 : 237 44.
9. Collinson J. The use of γ-interferon secretion in mixed lymphocyte culture and responsiveness to suppression by cyclosporin A as indicators of renal allograft rejection. MSc dissertation, University of Plymouth 2002.
10. Wirleitner B, Hoffmann G, Fuchs D. Neopterin and 7,8-dihydroneopterin in TH1-type immune response. Mod Asp Immunobiol 2005 15 : 36 40.
11. Bishop GA, Hall BM, Dugin G, Horvath JS, Sheil AR, Tiller DJ. Immunopathology of renal allograft rejection analysed with monoclonal antibodies to mononuclear cell markers. Kidney Int 1986 29 : 708 17.
12. Jose MD, Ikezumi Y, van Rooijen N, Atkins RC, Chadban SJ. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 2003 76 : 1015 22.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 1998 16 : 1215.
14. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab 2002 3 : 175 87.
15. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003 3 : 133 46.
16. Peng JC, Abu Baker S, Richardson MM et al. IL10 and IL12B polymorphisms each influence IL-12p secretion by dendritic cells in response to LPS. Immunol Cell Biol 2006 84 : 227 32.
17. Vilmaz V, Yentur SP, Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005 30 : 188 94.
18. Stanilova S, Miteva L. Taq-1 polymorphism in 3′UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun 2005 6 : 364 6.
19. Ghafari A, Makhdoomi K, Ahmadpour P, Afshari AT, Lak SS, Fakhri L. Serum T-lymphocyte cytokines cannot predict early acute rejection in renal transplantation. Transplant Proc 2007 39 : 958 61.
20. Sadeghi M, Daniel V, Weimer R, Wiesel M, Hergesell O, Opelz G. Pre-transplant Th1 and post-transplant Th2 cytokine patterns are associated with early acute rejection on renal transplant recipients. Clin Transplant 2003 17 : 151 7.
21. Tinckam K, Rush D, Hutchinson I et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 2005 79 : 836 41.
22. Loucaidou M, Stitchbury J, Lee J et al. Cytokine polymorphisms do not influence acute rejection renal transplantation under tacrolimus-based immunosuppression. Transplant Proc 2005 37 : 1760 1.
23. Verma N, He XY, Chen J et al. Interleukin 12 delays allograft rejection: effect mediated via nitric oxide. Transplant Proc 2001 33 : 416 17.
24. Fitzgerald JT, Johnson JR, Perez RV. Pre-transplant elevations of interleukin-12 and interleukin-10 are associated with acute rejection after renal transplantation. Clin Transplant 2004 18 : 434 9.
25. Butani L, Johnson J, Troppmann C, McVicar J, Perez RV. Predictive value of pretransplant inflammatory markers in renal allograft survival and rejection in children. Transplant Proc 2005 37 : 679 81.
26. Hoffmann SC, Stanley EM, Cox ED et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002 2 : 560 7.
27. Goriely S, Goldman M. The interleukin-12 family: new player in transplantation immunity? Am J Transplant 2007 7 : 278 84.
28. Grebe SO, Mueller TF. Immune monitoring in organ transplantation using neopterin. Curr Drug Metab 2003 3 : 189 202.
29. Margreiter R, Fuchs D, Hausen A et al. Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. Transplantation 1983 36 : 650 3.
30. Schafer AJ, Daniel V, Dreikorn K, Opelz G. Assessment of plasma neopterin in clinical kidney transplantation. Transplantation 1986 41 : 454 9.
31. Reibnegger G, Aichberger C, Fuchs D et al. Postransplant neopterin excretion in renal allograft recipients - a reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival. Transplantation 1991 52 : 58 63.
32. Lee PH, Huang MT, Chung YC et al. Monitoring of serum neopterin in renal transplant recipients. J Formos Med Assoc 1992 91 : 1209 12.
33. Weimer R, Susal C, Yildiz S et al. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens. Am J Transplant 2006 6 : 1865 74.
34. Brandacher G, Cakar F, Winkler C et al. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation. Kidney Int 2007 71 : 60 7.
35. Jungraithmayr TC, Reschke M, Grebe SO, Lange H, Radsak K, Mueller TF. Assessment of cytomegalovirus infections using neopterin and a new immunoblot. Clin Chim Acta 2001 310 : 63 9.